MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Metabolic brain changes related to specific cognitive impairment in non-demented Parkinson’s disease patients

M. Trošt, S. Brezovar, C.C. Tang, D. Eidelberg, N. Zupancic Kriznar, M. Gregoric Kramberger, P. Tomše, Z. Pirtošek (Ljubljana, Slovenia)

Meeting: 2016 International Congress

Abstract Number: 1306

Keywords: Cognitive dysfunction, Parkinsonism, Positron emission tomography(PET)

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Neuroimaging and neurophysiology

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To measure the expression of the Parkinson’s disease related cognitive pattern (PDCP) in 18F-FDG-PET brain images of Parkinson’s disease (PD) patients and healthy controls (HC) and to validate its correlation with subjects’ performance on cognitive tests.

Background: PDCP has been identified using a spatial covariance technique known as scaled subprofile model (SSM) based on principal component analysis (PCA) on 18F-FDG-PET images. It consists of covariate metabolic reductions in frontal and parietal association areas and relative increases in the cerebellar vermis and dentate nuclei. It has been shown that PDCP correlates with PD patients’ cognitive performance.

Methods: 18F-FDG-PET brain images of 20 non-demented PD patients (68±6 yrs old, 4±3 yrs PD duration, MDS-UPDRS-III: 38±10, MMSE: 29±2, MoCA: 26±3) and 20 HC (66±6 yrs old, MMSE: 29±1, MoCA: 27±2) were acquired. Different cognitive functions were assessed: attention (Trail making Test (TMT), verbal and non verbal memory (California Verbal Learning Test (CVLT II), Rey Complex Figure Test and Recognition Trial (RCFT)), visuospatial and visuoconstructional abilities (Rey Complex Figure (RCFT)), language (Verbal fluency test) and executive functions (Stroop Test, Tower test). The subject scores representing expressions of PDCP were calculated in the scans of individual subjects using Topographic Profile Rating (TPR). Correlations between PDCP subject scores and corresponding scores of each neuropsychological test were assessed by computing Pearson correlation coefficient.

Results: The expression of PDCP was significantly increased in PD patients compared to HC (p<0.001). PDCP expression correlated significantly with MoCA score in PD patients (R2=0.31, p=0.01). PDCP expression correlated significantly with attention (p<0.05, TMT Trial A) and s executive functions (p<0.05, Stroop test; p<0.05, TMT Trial B). Moreover, PDCP expression significantly correlated with learning curve (p<0.05), short delay free recall (p<0.05), and long delay free recall (p<0.05) measured by CVLT II. However, correlation between language and visuospatial abilities failed to reach significance.

Conclusions: PDCP has shown to be a reproducible imaging marker of cognitive dysfunction in PD. It correlates well with global cognitive score as well as with more specific, predominantly frontal cognitive domains.

To cite this abstract in AMA style:

M. Trošt, S. Brezovar, C.C. Tang, D. Eidelberg, N. Zupancic Kriznar, M. Gregoric Kramberger, P. Tomše, Z. Pirtošek. Metabolic brain changes related to specific cognitive impairment in non-demented Parkinson’s disease patients [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/metabolic-brain-changes-related-to-specific-cognitive-impairment-in-non-demented-parkinsons-disease-patients/. Accessed October 11, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/metabolic-brain-changes-related-to-specific-cognitive-impairment-in-non-demented-parkinsons-disease-patients/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley